Recurrent Cerebral Infarction Due to Moyamoya Disease Complicated With Systemic Lupus Erythematosus

Introduction: We report a rare case of moyamoya disease caused by an RNF213 mutation, complicated with systemic lupus erythematosus. Case Report: A 32-year-old woman experienced 4 cerebral ischemia stroke events within 6 months. The main symptom was left limb weakness with blurred vision in the right eye. Results of digital subtraction angiography conducted at another hospital were consistent with moyamoya disease. On genetic testing, we found that the patient carried 2 mutations in the moyamoya disease-related gene RNF213 (p.R4810K, p.T1727M). On the basis of the laboratory immunologic indicators, such as positive antibodies and abnormal immunoglobulin levels and imaging examinations, the patient was finally diagnosed as moyamoya disease complicated with systemic lupus erythematosus. She was treated with aspirin, butylphthalide, urinary kallidinogenase, and sodium methylprednisolone. Conclusions: This was a 32-year-old young patient diagnosed with moyamoya disease carrying RNF213 gene mutation and accompanied by lupus with cerebral ischemic event as the first occurrence. The patient’s condition was complex; therefore, comprehensive analysis and in-depth consideration were needed to avoid a missed diagnosis and misdiagnosis. When the primary disease cannot be identified, genetic testing can help to clarify the diagnosis of moyamoya disease.

[1]  B. Hu,et al.  Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency , 2023, Brain and behavior.

[2]  S. Dubey,et al.  Moyamoya angiopathy unmasking systemic lupus erythematosus , 2021, BMJ Case Reports.

[3]  Gyeong-Moon Kim,et al.  Role of the RNF213 Variant in Vascular Outcomes in Patients With Intracranial Atherosclerosis , 2020, Journal of the American Heart Association.

[4]  Wanyang Liu,et al.  Meta‐analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease , 2020, European journal of neurology.

[5]  Dong-Sook Kim,et al.  Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea , 2020, Stroke.

[6]  J. Buyon,et al.  Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. , 2020, Mayo Clinic proceedings.

[7]  Seung-Chyul Hong,et al.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy , 2019, Translational Stroke Research.

[8]  H. Maruyama,et al.  Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis. , 2019, Stroke.

[9]  C. Gordon,et al.  2019 update of the EULAR recommendations for the management of systemic lupus erythematosus , 2019, Annals of the rheumatic diseases.

[10]  M. Chimenti,et al.  Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view. , 2019, Autoimmunity reviews.

[11]  Y. Liu,et al.  Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report , 2018, Clinical Neurology and Neurosurgery.

[12]  Zhen-Ni Guo,et al.  Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence , 2017, International journal of stroke : official journal of the International Stroke Society.

[13]  H. Yoo,et al.  Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. , 2016, Journal of neurosurgery.

[14]  Melvyn W B Zhang,et al.  A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. , 2016, Autoimmunity reviews.

[15]  T. Huizinga,et al.  Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives , 2016, Drugs.

[16]  Jong S. Kim Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis , 2016, Journal of stroke.

[17]  Sukhum Silpa-archa,et al.  Ocular manifestations in systemic lupus erythematosus , 2015, British Journal of Ophthalmology.

[18]  S. Muller,et al.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers , 2014, Nature Reviews Neurology.

[19]  J. Hanly Diagnosis and management of neuropsychiatric SLE , 2014, Nature Reviews Rheumatology.

[20]  T. Tominaga,et al.  Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene , 2014, Journal of stroke.

[21]  H. Ahn,et al.  Incidence, Prevalence, and Survival of Moyamoya Disease in Korea: A Nationwide, Population-Based Study , 2014, Stroke.

[22]  S. Nam,et al.  Moyamoya syndrome occurred in a girl with an inactive systemic lupus erythematosus , 2013, Korean journal of pediatrics.

[23]  S. Gokhale,et al.  Moyamoya Syndrome as an Unusual Presenting Manifestation of Systemic Lupus Erythematosus in a Young Woman , 2013, Medical Principles and Practice.

[24]  Y. Xu,et al.  Systemic lupus erythematosus associated with moyamoya syndrome: a case report and literature review , 2013, Lupus.

[25]  R. Zong,et al.  Moyamoya Disease in China: Its Clinical Features and Outcomes , 2012, Stroke.

[26]  C. Mok,et al.  Moyamoya phenomenon in systemic lupus erythematosus. , 2011, Rheumatology.

[27]  S. Steens,et al.  Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. , 2011, Arthritis and rheumatism.

[28]  B. Bendok,et al.  Moyamoya disease: a summary. , 2009, Neurosurgical focus.

[29]  Young Jin Kim,et al.  Moyamoya syndrome associated with systemic lupus erythematosus , 2008, Lupus.

[30]  S. Kuroda,et al.  Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[31]  W. Chung,et al.  Systemic Lupus Erythematosus Associated with Familial Moyamoya Disease , 2003, The Korean journal of internal medicine.

[32]  K. E. el Ramahi,et al.  Systemic lupus erythematosus associated with moyamoya syndrome , 2000, Lupus.

[33]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[34]  M. Kiriakidou,et al.  Systemic Lupus Erythematosus , 1991, Annals of Internal Medicine.

[35]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.